House bill · H.R. 4191 (119th Congress)
MAPS Act
U.S. House of Representatives
Sponsor: Doris O. Matsui (U.S. Representative, CA-7, Democratic)
Following needs an Agora account. You will sign in first, then come back to this page.
From Congress.gov and official rosters. This record was last updated Sep 8, 2026. About our data
Summary
Mapping America’s Pharmaceutical Supply Act or the MAPS Act This bill requires the Food and Drug Administration (FDA) to continually update its essential medicines list and identify risks and vulnerabilities in the associated supply chains. In 2020, in response to an executive order, the FDA published a list of essential medicines deemed medically necessary to have available at all times. The bill requires the FDA to update and maintain this list to include drugs and ingredients (1) related to responding to public health threats and emergency incidents, (2) that are of greatest priority for providing health care and are at high risk of shortage, and (3) the shortage of which would adversely affect patients with chronic conditions. The FDA must review the list at least every two years and update it as appropriate. Also, the bill requires the FDA to conduct a risk assessment of the supply chains for drugs and ingredients on the list and annually report its findings to Congress. The assessment must include information about key manufacturing materials, drugs with primarily foreign or single suppliers, manufacturing capacity, relevant public health and national security risks, and risk mitigation strategies. Additionally, the Department of Health and Human Services (HHS) must map and monitor relevant supply chains to identify vulnerabilities and provide an annual status report to Congress. HHS must facilitate the secure exchange of information among agencies regarding locations and quantities of production and relevant regulatory actions.
Summary from the Congressional Research Service. How we handle summaries
Where it stands
Assigned to a committee for review.
- Introduced
- In committee
- Up for a vote
- Passed one chamber
- Passed
- Enacted
Committee
House Committee on Energy and Commerce · U.S. House of Representatives
Your position on this bill
Choose the position closest to yours. You'll sign in or create an account to save it.
Cosponsors
Showing the cosponsors who are on Agora, A to Z. The official record may list more.
Read on Congress.gov (opens in a new tab)- Republican2
Shown in neutral colors by design; Agora is non-partisan.
Related bills
As identified by Congress.gov.
Full history
- Jun 23, 2026
Introduced
Introduced in U.S. House
U.S. House
- Jun 26, 2025
Introduced
Introduced in House
U.S. House of Representatives
- Jun 26, 2025
In committee
Referred to the House Committee on Energy and Commerce.
U.S. House
- Jun 26, 2025
Referred to committee
Referred to the House Committee on Energy and Commerce.
U.S. House of Representatives
Read the record
- Read on Congress.gov (opens in a new tab) The official record on Congress.gov.